B. Metzler seel. Sohn & Co. AG Has $4.10 Million Stock Holdings in CVS Health Corporation $CVS

B. Metzler seel. Sohn & Co. AG trimmed its stake in shares of CVS Health Corporation (NYSE:CVS) by 2.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 60,469 shares of the pharmacy operator’s stock after selling 1,461 shares during the quarter. B. Metzler seel. Sohn & Co. AG’s holdings in CVS Health were worth $4,097,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Whitebox Advisors LLC acquired a new position in CVS Health during the 4th quarter worth approximately $249,000. Jennison Associates LLC grew its holdings in CVS Health by 503.8% during the 1st quarter. Jennison Associates LLC now owns 1,896,341 shares of the pharmacy operator’s stock worth $128,477,000 after acquiring an additional 1,582,257 shares during the last quarter. Cerity Partners LLC grew its holdings in CVS Health by 25.0% during the 1st quarter. Cerity Partners LLC now owns 648,266 shares of the pharmacy operator’s stock worth $43,920,000 after acquiring an additional 129,535 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in CVS Health by 2.1% during the 1st quarter. Bank of New York Mellon Corp now owns 8,981,262 shares of the pharmacy operator’s stock worth $608,481,000 after acquiring an additional 183,813 shares during the last quarter. Finally, Fairfax Financial Holdings Ltd. Can bought a new stake in CVS Health during the 4th quarter worth approximately $121,742,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on CVS. Cowen reissued a “buy” rating on shares of CVS Health in a report on Monday, August 4th. Cantor Fitzgerald reissued an “overweight” rating and set a $78.00 target price on shares of CVS Health in a report on Tuesday. Wells Fargo & Company reissued an “overweight” rating and set a $84.00 target price (up from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Truist Financial boosted their target price on shares of CVS Health from $82.00 to $84.00 and gave the stock a “buy” rating in a report on Monday, May 12th. Finally, Wall Street Zen raised shares of CVS Health from a “hold” rating to a “buy” rating in a report on Friday, May 9th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $77.56.

Insider Transactions at CVS Health

In related news, Director Guy P. Sansone bought 1,570 shares of the business’s stock in a transaction that occurred on Thursday, June 5th. The shares were acquired at an average cost of $63.70 per share, with a total value of $100,009.00. Following the completion of the purchase, the director directly owned 12,007 shares in the company, valued at $764,845.90. The trade was a 15.04% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.22% of the stock is currently owned by corporate insiders.

CVS Health Trading Up 0.5%

CVS opened at $71.94 on Thursday. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $72.51. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74. The company has a fifty day moving average of $65.76 and a 200-day moving average of $65.46. The stock has a market cap of $91.24 billion, a PE ratio of 20.09, a price-to-earnings-growth ratio of 0.79 and a beta of 0.58.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The company had revenue of $98.92 billion during the quarter, compared to analysts’ expectations of $94.87 billion. During the same period in the prior year, the company posted $1.83 earnings per share. CVS Health’s revenue for the quarter was up 8.4% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, sell-side analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 1st. Investors of record on Tuesday, July 22nd were paid a dividend of $0.665 per share. The ex-dividend date of this dividend was Tuesday, July 22nd. This represents a $2.66 annualized dividend and a yield of 3.7%. CVS Health’s dividend payout ratio is currently 74.30%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.